Dr. Rubin used a novel approach to target the gene fusion that causes epithelioid hemgioendothelioma, engineering a novel, first-of-its-kind mouse model of the disease, which will help advance studies to identify new treatments.

Click here to read the full article.

Sharing exciting news highlighting Dr. Brian Rubin’s research at the Lerner Research Institute at Cleveland Clinic! Dr. Rubin shared his thoughts on his success with us directly as well: “This is real progress and we continue to make substantial progress with our mouse model. It’s a very exciting time for EHE research as we see a lot of things we have been working on over the last several years starting to get results.”